LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

Search

Laboratory Corp of America Holdings

Uždarymo kaina

SektoriusSveikatos priežiūra

265.56 2.66

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

258.52

Max

268.21

Pagrindiniai rodikliai

By Trading Economics

Pajamos

113M

278M

Pardavimai

22M

3.5B

P/E

Sektoriaus vid.

22.968

50.958

Pelnas, tenkantis vienai akcijai

4.25

Dividendų pajamingumas

1.13

Pelno marža

7.858

Darbuotojai

71,000

EBITDA

130M

548M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+19.83% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

1.13%

2.41%

Kitas uždarbis

2026-07-23

Kitas dividendų mokėjimo data

2026-09-10

Kita Ex Dividend data

2026-08-27

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-424M

21B

Ankstesnė atidarymo kaina

262.9

Ankstesnė uždarymo kaina

265.56

Naujienos nuotaikos

By Acuity

60%

40%

288 / 342 reitingas Healthcare

Laboratory Corp of America Holdings Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Apie bendrovę Laboratory Corp of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
help-icon Live chat